M.I.TECH Co.Ltd (179290) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of M.I.TECH Co.Ltd stock KRW 9,272, price KRW 3,780, upside +145.3%, quality 68 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range 3,780 KRW – 15,151 KRW · fair‑value band 5,444 KRW – 13,757 KRW · the 3,780 KRW price screens below the 9,272 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow M.I.TECH Co.Ltd in your weekly email
Every Wednesday you see whether M.I.TECH Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names.
Show moreShow less
It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment.
The company was formerly known as Solco Intermed Co., Ltd. and changed its name to M.I.TECH Co.,Ltd in March 1999. M.I.TECH Co.,Ltd was founded in 1991 and is headquartered in Pyeongtaek-Si, South Korea. M.I.TECH Co.,Ltd operates as a subsidiary of Synergy Innovation Co., Ltd.
Stock analysis
M.I.TECH Co.Ltd (179290) currently trades at 3,780 KRW, while our model-based Fair Value estimate is 9,272 KRW, implying the stock looks roughly 59% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 14,604 KRW per share, and 23 of the 26 models we run sit above the 3,780 KRW price.
Bear case: the Dividend Discount group reads lowest at 1,068 KRW, and 3 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: 5,444 KRW (bear) to 13,757 KRW (bull), the price of 3,780 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
M.I.TECH Co.Ltd reported revenue of 67.2B KRW in FY2025 versus 50.3B KRW in FY2021, a compound +7.5%/yr. Reported net income was 20.3B KRW in FY2025, compounding +13.5%/yr from FY2021.
Key figures
Market cap 122B KRW (≈ $90.5M) Micro · P/E ratio 5.9 · P/S ratio 1.73 · EPS (TTM) 640.36 KRW · Dividend yield 3.2% · Net margin 29.3% · Return on equity 16.4% · Return on assets (EBIT) 16.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 81 out of 100 (low confidence).
What moves the price
The share trades about 52% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 145%, 179290 screens cheaper than that median.
Fair Value models
Bear5,444 KRWFair Value 9,272 KRWBull13,757 KRW
Price 3,780 KRW · Upside +145.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (446.23 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.84/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+24.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Start year 2020 (pandemic). Over 10 years: +18.2% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.2%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+27.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+24.0%
Dividend (yield on the price)3.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.24.0% vs 22.2%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 31%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−8.6%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −10.5% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score68 · Top 25%
Fair Value upside+145.3% · Top 25%
Profitability
Return on equity (12 months)16.4% · Top 25%
Return on assets14.3% · Top 25%
Net margin (12 months)29.3% · Top 25%
Operating margin (12 months)29.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)26.1% · Top 25%
Dividend yield (12 months)3.2% · Top 25%
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "M.I.TECH Co.Ltd Fair Value". https://www.fairvalue-calculator.com/stock/179290
Frequently asked questions
Is M.I.TECH Co.Ltd (179290) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 9,272 KRW versus a price of 3,780 KRW, about +145% upside (undervalued).
What is the fair value of 179290?
Our model-based fair value for M.I.TECH Co.Ltd is 9,272 KRW (as of Nov 5, 2026), built from audited fundamentals. The current price: 3,780 KRW.
What is the quality score of 179290?
M.I.TECH Co.Ltd has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for M.I.TECH Co.Ltd (179290)?
Our model-based price target is the fair value of 9,272 KRW (as of Nov 5, 2026) from 26 valuation models. Cautious scenario 5,444 KRW, optimistic scenario 13,757 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the M.I.TECH Co.Ltd stock forecast for 2026?
Our models put fair value at 9,272 KRW, about +145% upside versus a price of 3,780 KRW (undervalued). Cautious scenario 5,444 KRW, optimistic scenario 13,757 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of M.I.TECH Co.Ltd (179290)?
M.I.TECH Co.Ltd reported trailing-twelve-month revenue of about 70.7B KRW (latest available figure, as of Nov 5, 2026).
Does M.I.TECH Co.Ltd pay a dividend?
M.I.TECH Co.Ltd currently shows a dividend yield of 3.17% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of M.I.TECH Co.Ltd (179290) and when is the ex-dividend date?
M.I.TECH Co.Ltd pays a dividend of 120.00 KRW per share a year, a dividend yield of 3.2%. The last ex-dividend date was Dec 29, 2025. A dividend has been paid every year since at least 2018. The payout ratio is 18.7% of earnings. Free cash flow covers the dividend 2.55 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into M.I.TECH Co.Ltd (179290)?
For today's price to be fair in a discounted-cash-flow model, M.I.TECH Co.Ltd would have to grow free cash flow by -8.6 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.8 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of 179290 use?
Our models discount M.I.TECH Co.Ltd at 13.1 %: a base by market capitalisation (micro), country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For M.I.TECH Co.Ltd that is -8.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has M.I.TECH Co.Ltd (179290) delivered so far?
Over the past 5 years revenue at M.I.TECH Co.Ltd grew +10.8 % a year. The price currently implies free-cash-flow growth of -8.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of M.I.TECH Co.Ltd (179290) growing?
The median revenue growth in the sector is +14.3 % a year. That is the yardstick for the growth priced into M.I.TECH Co.Ltd (-8.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of M.I.TECH Co.Ltd (179290)?
The free-cash-flow yield on the price is 8.10 %: that much free cash flow M.I.TECH Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of M.I.TECH Co.Ltd (179290)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For M.I.TECH Co.Ltd it is 9,272 KRW per share (as of Nov 5, 2026), against a price of 3,780 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is M.I.TECH Co.Ltd stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 179290 trades below its calculated fair value: price 3,780 KRW, fair value 9,272 KRW, a gap of about +145% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 179290?
No. The price is what the market pays today (3,780 KRW); the fair value is what the company's own numbers justify (9,272 KRW). For M.I.TECH Co.Ltd the two are 5,492 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is M.I.TECH Co.Ltd worth?
The market values M.I.TECH Co.Ltd at about 122B KRW (market capitalisation, as of Nov 5, 2026). Per share that is 3,780 KRW; our models calculate a fair value of 9,272 KRW per share.
What do the bullish and bearish scenarios say about 179290?
Our models span a range for M.I.TECH Co.Ltd: cautious scenario 5,444 KRW, base 9,272 KRW, optimistic 13,757 KRW per share (as of Nov 5, 2026, price 3,780 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 179290?
M.I.TECH Co.Ltd trades at a price-to-earnings ratio of 5.9 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 9,272 KRW is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2018 to 2025), reported earnings: 17.8. Other multiples: P/B 1.0, P/S 1.7, EV/EBITDA 3.5.
How solid is the balance sheet of M.I.TECH Co.Ltd (179290)?
Balance-sheet figures for M.I.TECH Co.Ltd (as of Nov 5, 2026): return on equity 16.4%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is 179290 from its 52-week high?
M.I.TECH Co.Ltd trades at 3,780 KRW, about 52% below its 52-week high of 7,810 KRW and at the low of 3,780 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 9,272 KRW is for.
Which stocks are comparable to M.I.TECH Co.Ltd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is M.I.TECH Co.Ltd stock attractive at the current price?
The data as of Nov 5, 2026: price 3,780 KRW, calculated fair value 9,272 KRW (+145%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 179290 calculated?
We run M.I.TECH Co.Ltd through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 9,272 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. M.I.TECH Co.Ltd currently trades 59% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of M.I.TECH Co.Ltd (179290)?
The closing price on Nov 6, 2026 was 3,780 KRW. Our model-based fair value is 9,272 KRW, about +145% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with M.I.TECH Co.Ltd right now?
The price is below even our cautious bear case (5,444 KRW). The market is more pessimistic than our downside scenario. Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (5,444 KRW to 13,757 KRW) leaves room in how you read the outcome.
Key figures of M.I.TECH Co.Ltd
How large is the market capitalisation of M.I.TECH Co.Ltd (179290)?
The market capitalisation of M.I.TECH Co.Ltd is 122B KRW (≈ $90.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of M.I.TECH Co.Ltd (179290)?
The price-to-sales ratio of M.I.TECH Co.Ltd is 1.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of M.I.TECH Co.Ltd (179290)?
Earnings per share at M.I.TECH Co.Ltd are 640.36 KRW (price ÷ EPS = P/E 5.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of M.I.TECH Co.Ltd (179290)?
The dividend yield of M.I.TECH Co.Ltd is 3.2% (payout 18.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of M.I.TECH Co.Ltd (179290)?
The net margin of M.I.TECH Co.Ltd is 29.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of M.I.TECH Co.Ltd (179290)?
The return on equity (ROE) of M.I.TECH Co.Ltd is 16.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of M.I.TECH Co.Ltd (179290)?
On an EBIT basis the return on assets of M.I.TECH Co.Ltd is 16.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of M.I.TECH Co.Ltd (179290)?
The operating margin of M.I.TECH Co.Ltd is 29.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at M.I.TECH Co.Ltd (179290)?
Revenue at M.I.TECH Co.Ltd is growing +26.1% versus a year earlier (3y avg +6.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at M.I.TECH Co.Ltd (179290)?
Earnings per share at M.I.TECH Co.Ltd are growing +30.4% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch M.I.TECH Co.Ltd in the live analysis
One click puts M.I.TECH Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 5, 2026